关于 SDTM 您需要了解的一切
从 SDTM 实施指南到 SDTM 数据集创建的分步流程，了解有关 CDISC SDTM 的所有信息。
https://www.certara.com.cn/blog/everything-you-need-to-know-about-sdtm/
1494 个结果
研究治疗自身免疫性疾病疗效的定量系统药理学模型
本网络研讨会由国际药物统计学会（ISoP）主办 演讲者：；摘要;；针对 BAFF 和 APRIL 的治疗性拮抗剂治疗自身免疫性疾病的开发仍处于起步阶段，关于其作用机制和药效学（PD）特征以及如何优化其疗效仍存在许多问题。We developed a quantitative systems … Continued
https://www.certara.com.cn/on-demand-webinar/a-quantitative-systems-pharmacology-model-to-study-the-efficacy-of-therapies-for-the-treatment-of-autoimmune-disease/人工智能驱动的 QSP 建模
地点MassBioHub, 700 Technology Square, 5th Floor, Cambridge, MA 02139 The proliferation of powerful AI models has revolutionized how the life sciences industry consumes information and uses it for accelerating and validating research. For example: One area where AI can provide immense value is in combination with QSP modeling to significantly accelerate the creation, expansion and validation … Continued
https://www.certara.com.cn/live-events/ai-powered-qsp-modeling/SDTM Mapping & SDTM Conversion
Make earlier safety & efficacy decisions with rapid trial insights It takes a load of time and effort to convert source data into Study Data Tabulation Model, or SDTM format. 要完成这项工作，通常需要昂贵的编程资源。And when it’s left until the end of a trial, you risk costly … Continued
https://www.certara.com.cn/pinnacle-21-enterprise-software/sdtm-mapping-sdtm-conversion/Best Practices for a Successful eCTD Submission
Learn common pitfalls that pharmaceutical sponsors encounter during the regulatory eCTD submission procedure and best practices for addressing them.
https://www.certara.com.cn/blog/best-practices-for-a-successful-ectd-submission/Thank you for your download request
https://www.certara.com.cn/thank-you-content-download-services/
Simcyp™ Simulator 的新功能 — 从监管进展到新模式
Already the most sophisticated technology for physiologically based pharmacokinetic modeling (PBPK), the Simcyp Simulator has added a range of new advances in its recently release (version 23). This webinar, hosted by the subject matter expert scientists at Simcyp, will share these new capabilities and review the features that have enabled the Simulator to be leveraged … Continued
https://www.certara.com.cn/on-demand-webinar/whats-new-in-the-simcyp-simulator-from-regulatory-advances-to-new-modalities/Waiving clinical studies & accelerating drug development for kinase inhibitor drugs eBook
Speed up Drug Development for Kinase Inhibitors: Free eBook Unlock the key to faster drug development with our eBook, “Waiving Clinical Studies & Accelerating Drug Development for Kinase Inhibitor (KI) Drugs.” Whether you’re in pre, early, or late clinical stages to post-marketing, this essential resource offers real-world case studies and insights into the power of … Continued
https://www.certara.com.cn/waiving-clinical-studies-accelerating-drug-development-for-kinase-inhibitor-drugs-ebook/Thank You – Content Download – Simcyp
How about a free demo of the Simcyp™ PBPK Simulator? Complete the form to book your no-obligation demo of the standard software for Population-based Physiologically Based Modeling and Simulation… and see how better off you could be with Simcyp!
https://www.certara.com.cn/thank-you-content-download-simcyp/Certara CERTAINTY 2024
Transcript: The Certara community and interdisciplinary industry experts and scientists from model and form drug development bio simulation, clinical pharmacology, regulatory science, and software development come together for Certainty. Certara’s first annual client summit. This coming May fourteenth through sixteenth in Philadelphia at Convene. We will unite to share future visions, strategies, industry trends, and … Continued
https://www.certara.com.cn/video/certainty-by-certara-2024/
